Number of pages: 100 | Report Format: PDF | Published date: May 11, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
Report Attribute |
Details |
Market Size Value in 2022 |
US$ 5.61 billion |
Revenue Forecast in 2031 |
US$ 7.92 billion |
CAGR |
3.90% |
Base Year For Estimation |
2022 |
Forecast Period |
2023 to 2031 |
Historical Year |
2021 |
Segments Covered |
Drug Class, Route of Administration, Distribution Channel, and Region |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global birch allergy treatment market was valued at US$ 5.61billion in 2022 and is expected to register a revenue CAGR of 3.90% to reach US$ 7.92 billion by 2031.
Birch Allergy Treatment Market Fundamentals
Birch allergy is a common type of allergy that affects many people globally. While several treatment options are available, new trends have emerged in recent years that offer promising alternatives to traditional treatment methods. For instance, recently, sublingual immunotherapy and biologics have gained popularity for treating birch allergies. These new treatments have shown promising results and may provide more effective relief for people with birch allergies. For instance, in June 2019 ALK-Abello obtained EMA approval for ITULAZAX, the only sublingual immunotherapy tablet for the treatment of grass pollen allergy.
Several opportunities in birch allergy offer the potential for improved diagnosis, management, and treatment of the condition. The gold standard for diagnosis currently involves a skin prick or blood test. Although emerging technologies such as molecular-based diagnostic techniques may offer enhanced sensitivity and specificity. Moreover, there is potential for public health campaigns and education initiatives to raise awareness of birch allergy and the need for early diagnosis and treatment.
The global birch allergy treatment industry analysis report comprehensively analyzes the market, with the factors that either aid or impede the market growth, such as its drivers, restraints, and opportunities. The research provides insight into the companies that operate in the Birch Allergy Treatment market and their efforts to position themselves as key players through expansion strategies and innovations. It also highlights recent developments that contribute to the Birch Allergy Treatment market growth. The research also analyzes the impact of the COVID-19 pandemic.
This research is valuable for businesses seeking insights into the market, customers, and competition. The study provides special insights into the segmentation, regions, market size & projection, revenue CAGRs, and other important information that may help clients make the right decisions. The report assembles data from market players and professionals across the industrial value chain. The study also incorporates qualitative and quantitative assessments from industry professionals. Secondary research, surveys and interviews, and statistical modeling are all used in our research to estimate market size and projection. Our reports deliver the most reliable market data because of our specialized research methods.
[12121]
Birch Allergy Treatment Market Dynamics
The rising prevalence of birch allergy is a prominent factor in the global birch allergy treatment market. As stated by Annals of Allergy, Asthma & Immunology in 2021, birch trees caused allergic rhinitis in over 100 million individuals globally. Birch pollen sensitization affects an estimated 20% to 30% of patients with respiratory allergies in North America and Europe. Recent estimates from the Copernicus Atmosphere Monitoring Service (CAMS) reveal that birch pollen levels are rapidly increasing in various regions of Europe, including northern Italy, Switzerland, and southern Germany. According to the 2022 estimates by European Climate and Health Observatory, pollen allergy is believed to affect 40% of the European population, which makes it among the most common allergic diseases. Additionally, ongoing research and development in this area are expected to introduce novel treatments in the forecast years. For instance, a cocktail of Bet v 1-specific antibodies is offering a new standard for the treatment of birch allergy.
Birch Allergy Treatment Market Ecosystem
Birch Allergy Treatment Market, by Drug Class
Birch Allergy Treatment Market, by Route of Administration
Birch Allergy Treatment Market, by Distribution Channel
Birch Allergy Treatment Market by Route of Administration
[258963]
The oral route of administration accounted for 54% of the market share in 2022. Oral administration is a preferred method for birch allergy treatment due to its convenience and ease of use. Furthermore, it allows for accurate dosing and can be self-administered, reducing the need for frequent visits to healthcare facilities. Oral drugs are also safer to administer in children, therefore contributing to the high demand in this segment. Additionally, increasing trends of sublingual immunotherapy have shown high efficacy in treating birch allergies and can provide long-lasting relief.
The market segmentation sections provide the birch allergy treatment market outlook in terms of the demarcation of different consumer groups. Market segmentation is splitting an industry into subgroups depending on characteristics such as drug class, route of administration, distribution channel, and region. Market segmentation data helps organizations understand the preferences and distinctive demands of different customer groups and implement targeted marketing strategies. This data additionally helps in identifying potential Birch Allergy Treatment market demand opportunities.
Birch Allergy Treatment Market by Region
North American region is expected to account for 49% of the market share in 2022. This is attributed to the increasing prevalence of allergies and the growing demand for advanced treatments. Furthermore, factors such as rising healthcare expenditure and the presence of key market players also contribute to the growth of the allergy treatment market in North America.
The European region accounts for 43% of the global birch allergy treatment market share. This is majorly attributed to the presence of birch trees in Northern and Central Europe, which is a major cause of allergic rhinitis and, perhaps, asthma symptoms. In 2019, The Department of Dermatology and Allergology stated that in Europe, the prevalence of birch pollen sensitization ranges from approximately 8% to 16%. Moreover, increased research and development on birch allergy is anticipated to introduce new treatments for birch allergy.
Based on the regions, the global birch allergy treatment market is segmented into:
The industry's regional segmentation provides insights into geographic pockets in terms of Birch Allergy Treatment industry trends, market size, share, and growth rate. This information helps organizations assess potential growth opportunities in new regional markets, understand competitive threats, and develop localized sales and expansion strategies. This section also offers deeper insights into the regional and country-level birch allergy treatment market overview.
Key Components of the Report
Birch Allergy Treatment Market Competitive Landscape
The market competitive landscape analysis is performed by gathering and evaluating data about the key competitors, industry trends, and market dynamics. It involves collecting and analyzing data on factors such as products, pricing, geographic reach, customer demographics, marketing tactics, and recent developments. Competitive landscape analysis can help organizations identify present or prospective opportunities and risks in the market.
Birch Allergy Treatment Market Strategic Developments
Reasons To Buy This Report
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Birch allergy is a type of pollen allergy that causes symptoms such as sneezing, runny nose, and itchy eyes. It is commonly triggered by exposure to birch tree pollen during the spring season.
The global birch allergy treatment market was valued at US$ 5,617.7 million in 2022.
North America accounted for 49% of the birch allergy treatment market from 2023 to 2031.
The global birch allergy treatment market was valued a revenue CAGR of 3.90 % during the forecast period from 2023 to 2031.
The global birch allergy treatment market was valued at US$ 7,926.8 million by 2031.
One of the most effective birch allergy treatment industry trends is the development of sublingual immunotherapy.
The global birch allergy treatment market is expected to grow significantly in the coming years due to the increasing prevalence of birch pollen allergies in the Northern hemisphere and the rising demand for effective treatments.
One of the key challenges is the lack of awareness about birch allergy treatment options among patients and healthcare professionals.
Mergers and acquisitions, product innovation, strategic partnerships, and strengthening of the pipeline are the major strategies adopted by key market players in the birch allergy treatment market.
*Insights on financial performance are subject to the availability of information in the public domain